Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2022 | |
Document and Entity Information [Abstract] | |
Document Type | PRE 14A |
Entity Registrant Name | Capricor Therapeutics, Inc. |
Entity Central Index Key | 0001133869 |
Amendment Flag | false |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure [Table] | ||
Pay vs Performance [Table Text Block] | Value of Initial Fixed $100 Investment Based On: Summary Compensation Average Summary Average Compensation Total Compensation Table Actually Compensation Table Total Actually Paid to Shareholder Net Year Total for PEO (1) Paid to PEO (2) for Non-PEO NEO (1) Non-PEO NEO (2) Return Income/(Loss) (3) 2022 $ 1,333,423 $ 2,202,319 $ 796,066 $ 820,990 $ 113 $ (29,019,532) 2021 1,790,548 1,141,722 702,120 539,686 85 (20,022,520) | |
PEO Total Compensation Amount | $ 1,333,423 | $ 1,790,548 |
PEO Actually Paid Compensation Amount | 2,202,319 | 1,141,722 |
Non-PEO NEO Average Total Compensation Amount | 796,066 | 702,120 |
Non-PEO NEO Average Compensation Actually Paid Amount | $ 820,990 | 539,686 |
Compensation Actually Paid vs. Total Shareholder Return [Text Block] | Compensation Actually Paid and Company TSR | |
Compensation Actually Paid vs. Net Income [Text Block] | Compensation Actually Paid and Net Loss | |
Total Shareholder Return Amount | $ 113 | 85 |
Net Income (Loss) | $ (29,019,532) | $ (20,022,520) |